Recent Articles

December 17, 2014 4:35 pm
Cynthia Fox, Science Writer
Some 45% of deaths are caused by fibrosis (scar tissue) diseases, including idiopathic pulmonary fibrosis, cirrhosis, and heart and kidney failure. But a Harvard University group reports in Cell Stem Cell they have discovered a key cause of that fibrosis: a stem-cell-like perivascular cell called Gli1+, found in blood vessels. Read more...
December 17, 2014 12:52 pm
Roger Humphrey, Executive Managing Director, Life Sciences Americas, JLL
Patent origin location has become the latest way patent applications can inform business strategy, and recent analysis shows where innovation hubs are on the rise. The United States and Europe have enjoyed long deep-seated roots as the leaders of high-value aspects of the biopharmaceutical development cycle, such as new product research and development (R&D). Read more...
December 16, 2014 2:38 pm
Ryan Bushey, Associate Editor
The price of one pill has placed Gilead Sciences in the middle of a lawsuit. Read more...                             
December 15, 2014 4:47 pm
Stephanie Guzowski, Editor
Three exceptional women were given awards for their achievements and contributions to the scientific community at the 2014 ASCB (American Society for Cell Biology) meeting recently held in Philadelphia, Pa. Read more...                               
December 15, 2014 2:19 pm
Skip Derra, Contributing Writer
A novel therapeutic to fight colon cancer by using the bacteria primarily responsible for causing strep throat is being explored in the labs of John McCormick of the Schulich School of Medicine & Dentistry at the University of Western Ontario, London, Ontario, Canada. Read more...
December 11, 2014 11:25 am
Kathleen A. Martin, Ph.D., Senior Research Chemist, McCrone Associates, Inc.
Raman spectroscopy has steadily gained a wider role in the pharmaceutical industry because of its applicability to several important aspects of drug development and manufacturing. Read more...                         
December 8, 2014 11:57 am
Drug Discovery & Development Staff
Tamoxifen, the leading estrogen blocker, has done so well by hormone receptor-positive breast cancer patients that the American Society for Clinical Oncology (ASCO) changed its guidelines this year, advising certain patients to take the drug for ten years instead of five. Read more...
December 5, 2014 9:43 am
Jonathan Sheldon, PhD, global vice president, Oracle Health Sciences
With the evolution of electronic medical records (EMR) systems, and the integration of genomic data with multi-dimensional longitudinal clinical data, the opportunity is rife to build truly personalized approaches to patient care. 
December 2, 2014 9:52 am
Stephanie Guzowski, Editor
If you could take a blood test that could detect — with nearly 100% accuracy — whether you were genetically destined to get Alzheimer’s disease, would you take that test? Read more...
November 28, 2014 9:55 am
Cynthia Fox, Science Editor
Ian Wilmut, father of the cloned Dolly the Sheep, is now proposing to father a global induced pluripotent stem (iPS) cell handbook— to go with a proposed new global network of iPS cell haplobanks. Read more...                                   
Subscribe to Drug Discovery & Development